Four new meroterpenoids, named chrodrimanins D-G (4-7), and one known compound, renamed chrodrimanin H (8), were isolated from okara (the insoluble residue of whole soybean) that had been fermented with the YO-2 strain of Talaromyces sp. Their structures were elucidated by spectroscopic methods. Chrodrimanins D (4), E (5), and F (6) showed insecticidal activity against silkworms with respective LD 50 values of 20, 10, and 50 g/g of diet.
Microorganisms are a prolific source of structurally interesting and biologically active metabolites. Fungi of the genus Talaromyces have been reported to produce penicillide, 1) dehydroisopenicillide, 1) and kasanosin C. Metabolites produced by T. flavus have also been reviewed. 3) We have reported in a previous paper 4) that YO-2 of Talaromyces sp. produced a new chrodrimanin conger, chrodrimanin C, together with chrodrimanins A and B, and that chrodrimanin B showed insecticidal activity against silkworms. Chrodrimanins are considered to be meroterpenoids consisting of sesquiterpenoid and pentaketide moieties, and only the pentacecilide family has been reported to have the same carbon skeleton as chrodrimanins with different stereochemistry. Our continuing efforts to find new chrodrimanin congeners to elucidate their structure-activity relationships and also to enable the biosynthesis of chrodrimanins have led to the isolation of chrodrimanins D-H (4) (5) (6) (7) (8) . This paper reports the structures of these new chrodrimanin congeners and their insecticidal activity against silkworms.
Materials and Methods
Melting point (mp) data are uncorrected and optical rotation was measured with a Jasco P-2100 polarimeter. IR spectra were recorded with a Jasco FT/IR-460 spectrophotometer, mass spectra were recorded with a Jeol JMS-700 instrument, and 1 H-and 13 C-NMR spectra were obtained with a Jeol JNM AL-400 spectrometer. Chemical shifts are referenced to residual CHCl 3 at 7.26 ppm for 1 H spectra and to CDCl 3 at 77.0 ppm for 13 C spectra, each being reported relative to TMS. Column chromatography was performed with Wakogel C-200 (Wako Pure Chemical Industries) and Inertsil ODS-3 (GL Sciences). The okara used as a medium in this experiment was kindly supplied by the Shirayukihime tofu (bean-curd) shop (Sakai, Osaka, Japan).
Bioassay. Bioassays using silkworms were carried out according to the procedure reported previously. 4) Fermentation. A loopful of spores from a slant culture of Talaromyces YO-2 was inoculated into 30 g of okara in a Petri dish of 9 cm in diameter and cultivation was carried out at 25 C for 14 d.
Isolation of 4, 5, 6, 7, and 8. Okara (10 kg) that had been fermented with the YO-2 strain was soaked in acetone. Evaporating the acetone gave an aqueous concentrate, which was extracted three times with EtOAc. The resulting EtOAc extract (13.3 g) was chromatographed on Wakogel C-200 by eluting with n-hexane and an increasing ratio of EtOAc to afford the 60-100% EtOAc eluates (4.3 g). After removing chrodrimanin B by crystallization and filtration, the filtrate (900 mg) was loaded into an Inertsil ODS-3 HPLC column (250 Â 10:0 mm) equipped with a photodiode array detector. Separation by isocratic elution with MeCN-water (60:40, v/v) at a flow rate of 2.36 mL/min gave chrodrimanin D (4, 5.0 mg, t R 13.9 min), chrodrimanin E (5, 20 mg, t R 20.8 min), chrodrimanin F (6, 1.0 mg, t R 15.6 min), chrodrimanin G (7, 2.0 mg, t R 17.7 min), and chrodrimanin H (8, 80 mg, t R 18.5 min).
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Results and Discussion
The YO-2 strain of Talaromyces sp. was cultured on okara, and okara mold was extracted with acetone. The aqueous acetone solution obtained by filtration was concentrated and extracted with EtOAc. Chromatographic separation of the resulting EtOAc extract afforded a fraction containing chrodrimanin B. After removing chrodrimanin B by crystallization and filtration, the filtrate was treated into an Inertsil ODS-3 HPLC column, resulting in the isolation of chrodrimanins D (4), E (5), F (6), G (7), and H (8).
The molecular formula for chrodrimanin D (4) was established as C 25 H 32 O 7 on the basis of HR-EIMS, 1 H-, and 13 C-NMR spectra. Analysis of the NMR data (Tables 1 and 2 ) and their comparison with the formerly described compounds indicated the presence of rings C, D, and E, the same as those of chrodimamin C (3). Chrodrimanin D was found to contain two extra oxygen atoms than 3. The position of one hydroxy group at C-1 was established by the connectivity between H-1 ( 4.20) and H 2 -2 ( 2.42 and 3.05) in the COSY spectrum of 4 shown in Fig. 2 . This location was supported by the fact that the HMBC spectrum of 4 exhibited cross peaks between H 3 -15, H-5 and H-9 with C-1 as shown in Fig. 2 . The location of the other hydroxy group at C-7 was deduced by the linkage of H-5 ( 2.52), H 2 -6 ( 2.2-2.3, 1.79), and H-7 ( 4.08) shown in the COSY spectrum of 4, this assumption also being supported by HMBC correlations from the H-7 signal to C-12, C-9 and C-5. Rings A and B of chrodrimanin C were respectively determined to be in chair and boat forms, and the 1 H-NMR data for 4 supported rings A and B being in respective chair and boat forms. The NOE correlations between 4.20 (H-1) and the methyl signal (H 3 -15), and between 4.20 (H-1) and 2.57 (H-11) determined the hydroxy group at C-1 to be -oriented (Fig. 2) . Another hydroxy group at C-7 was determined to have -orientation due to a cross peak between 4.08 (H-7) and the methyl signal (H 3 -12) observed in the NOESY spectrum (Fig. 2 ) of 4.
The molecular formula for chrodrimanin E (5) was determined to be C 25 H 30 O 6 by the HR-EIMS and NMR data, indicative of 5 being a dehydroxy derivative of chrodrimanin A (1). The 1 H-NMR (Table 1 ) and 13 C-NMR ( Table 2 ) spectra indicated that rings A, B, C and D remained unchanged in 5. A hydroxy group at C-7 0 in 1 was substituted by a hydrogen atom in 5, because the connections from C-7 0 to C-9 0 via a methine C-8 0 were observed in the COSY spectrum of 5.
The molecular formula for chrodrimanin F (6) was established as C 25 H 34 O 6 by the HR-EIMS, 1 H-NMR (Table 1) , and 13 C-NMR (Table 2 ) data. Chrodrimanin F had four more hydrogen atoms than 5. An enone moiety in 5 was diminished in 6, and a new linkage of H 2 -1 ( 1.4-1.5 and 1.6-1.7), H 2 -2 ( 1.70 and 1.78), and H-3 ( 3.23) shown in the 1 H-1 H COSY spectrum (Fig. 2 ) appeared in 6, indicating that a hydroxy group was located at C-3. This hydroxy group was determined to be -oriented, because the cross peaks between H-3 and H-5 and between H-3 and the -methyl at C-4 were observed in the NOESY spectrum of 6 as shown in Fig. 2. A part of the rings of B, C, D and E in 6 was the same as that of 5 on the basis of the NMR data.
Chrodrimanin G (7) was found to have the molecular formula of C 27 H 34 O 8 by the HR-EIMS, 1 H-NMR (Table 1) , and 13 C-NMR (Table 2 ) data, indicating that 7 had the same molecular formula as that of dihydrochrodrimanin B. The spectral data for 7 were identical to those for the dihydro-derivative of chrodrimanin B reported in a previous paper, 4) resulting in the identification of chrodrimanin G as dihydrochrodrimanin B.
Since the spectral data for chrodrimanin H (8) were identical to those previously reported for thailandolide A, 5) 8 was identical to thailandolide A. Thailandolide A, however, should be renamed chrodrimanin H, because thailandolide B was identical to chrodrimanin B, as reported earlier in a previous paper.
4 ) The absolute configuration at C-8 0 for metabolites 4-8 was assigned to be R on biosynthetic grounds.
The insecticidal activity of chrodrimanins was evaluated by using 3rd instar larvae of silkworms and is summarized in Table 3 by the LD 50 values. The respective LD 50 values for chrodrimanins D (4), E (5), and F (6) were 20, 10, and 50 mg/g of diet. An acetoxy group at C-7 0 and a hydroxy group at C-7 had no effect on this activity, because chrodrimanins C (3), G (7), and H (8) showed no activity. This fact is also supported by the comparison of 2 with an acetoxy group at C-7 0 and 5 without it, both of which had the same LD 50 value of 10 mg/g of diet. An enone system seems to have played an essential role in exhibiting activity, because 2 and 5 showed the highest activity among the chrodrimanins, with the exception of chrodrimanins D (4) and F (6). A hydroxy group was at C-1 in 4 and substituted an enone system in 6. Hydrophobicity at ring E lowered the activity, because chrodrimanin A (1) containing an enone system in ring A and a hydoxy group at C-7 0 exhibited no activity. A clear structure-activity relationship among the chrodrimanins was not provided by the silkworm assay in this study. On the other hand, we have already reported the mode of action of the fungal metabolites, austin 6) and asperparaline, 7) by applying whole-cell patch-clamp electrophysiology. The precise structure-activity relationship and mode of action of chrodrimanins will be clarified in the near future by similarly using patch-clamp electrophysiology. Figure 3 shows the proposed biosynthetic pathway to 1-8 starting from 6-hydroxymellein 8, 9) and farnesyl pyrophosphate. The carbon skeleton of the chrodrimanins could be derived from precursors of a pentaketide and sesquiterpenoid moiety, indicating that chrodimanins can be considered to be meroterpenoids. Figure 3 shows that 6-hydroxymellein underwent alkylation with farnesyl pyrophosphate, resulting in the formation of intermediate 1 after epoxidation. Subsequent cyclization led to the formation of intermediate 2. Dehydrogenation at C-3 and hydroxylation at C-7 respectively converted intermediate 2 to chrodrimanins C (3) and F (6). Oxidation of 3 and 6 resulted in the formation of common compound 8. Hydroxylation at C-1 of 8 and subsequent dehydration, hydroxylation at C-7 0 , and acetylation at O-7 0 respectively led to 4, 5, 1 and 2, chrodrimanin H (8) also leading to 7. The biosynthetic pathway mentioned here is a plausible one, and experimental evidence to support this pathway should be proved in future experiments. The pentacecilide 10) has the same carbon skeleton as that of chrodrimanins, indicating that the pentacecilide could be biosynthesized by the same procedure as that shown in Fig. 3 . In the case of the pentacecilide, the step from intermediate 1 to intermediate 2 seems to be different from that of chrodrimanins. Other meroterpenoids consisting 6-hydroxymellein are coriandrones A, 11) B, 11) and D. 12) Oxygenated carbons in these compounds are the same as those in chrodrimanins, but an isoprene unit is attached to C-5 0 in the benzene ring of chrodrimanins. 
